<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ACM</journal-id><journal-title-group><journal-title>Advances in Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2161-8712</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/ACM.2021.113132</article-id><article-id pub-id-type="publisher-id">ACM-40835</article-id><article-categories><subj-group subj-group-type="heading"><subject>ACM20210300000_59144380.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  清热解毒方与软坚散结方对人肺腺癌A549细胞增殖及Bcl-2表达的影响
  Effects of Qingrejiedu Formula and Ruanjiansanjie Formula on Proliferation and Bcl-2 Expression of A549 Cells
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>冯</surname><given-names>欣</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>孙</surname><given-names>晓伟</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>王</surname><given-names>丽君</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>高</surname><given-names>哲</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>林</surname><given-names>存智</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>青岛大学附属医院，山东 青岛</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><aff id="aff2"><addr-line>青岛大学，山东 青岛</addr-line></aff><pub-date pub-type="epub"><day>04</day><month>03</month><year>2021</year></pub-date><volume>11</volume><issue>03</issue><fpage>918</fpage><lpage>924</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  
    目的：研究清热解毒方与软坚散结方对人肺腺癌A549细胞增殖及Bcl-2表达的影响。方法：将不同浓度的清热解毒方、软坚散结方分别作用于人肺腺癌A549细胞，CCK8法检测细胞生长抑制率，流式细胞仪检测细胞凋亡率，RT-PCR检测Bcl-2 mRNA表达。结果：清热解毒方、软坚散结方均呈剂量依赖性抑制A549细胞生长(P &lt; 0.05)，并下调Bcl-2 mRNA表达(P &lt; 0.05)。结论：清热解毒方、软坚散结方均能不同程度地抑制人肺腺癌A549细胞的增殖，其机制可能与下调Bcl-2 mRNA表达有关，从而促进人肺腺癌A549细胞凋亡。
    Objective: To study the effects of Qingrejiedu Formula and Ruanjiansanjie Formula on proliferation and Bcl-2 expression of human lung adenocarcinoma cancer cell A549. Methods: We added different concentrations of Qingrejiedu Formula and Ruanjiansanjie Formula to human lung adenocarcinoma cells A549 and CCK8 method was used to detect cellular proliferation. Flow cytometric was used to detect cell apoptotic. RT-PCR method was used to detect the mRNA expression of Bcl-2. Results: Qingrejiedu Formula and Ruanjiansanjie Formula inhibited the proliferation of A549 cells in a dose-dependent manner (P &lt; 0.05), and down-regulated the expression of Bcl-2 (P &lt; 0.05). Conclusion: Qingrejiedu Formula and Ruanjiansanjie Formula can inhibit the proliferation of A549 cell line in varying degrees, and the mechanism may down-regulate the expression of Bcl-2, so as to induce apoptosis of human lung adenocarcinoma cancer cell A549. 
  
 
</p></abstract><kwd-group><kwd>清热解毒方，软坚散结方，人肺腺癌A549细胞，Bcl-2, Qingrejiedu Formula</kwd><kwd> Ruanjiansanjie Formula</kwd><kwd> Human Lung Adenocarcinoma Cancer Cell A549</kwd><kwd> B-Cell Lymphoma-2</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>摘要</title><p>目的：研究清热解毒方与软坚散结方对人肺腺癌A549细胞增殖及Bcl-2表达的影响。方法：将不同浓度的清热解毒方、软坚散结方分别作用于人肺腺癌A549细胞，CCK8法检测细胞生长抑制率，流式细胞仪检测细胞凋亡率，RT-PCR检测Bcl-2 mRNA表达。结果：清热解毒方、软坚散结方均呈剂量依赖性抑制A549细胞生长(P &lt; 0.05)，并下调Bcl-2 mRNA表达(P &lt; 0.05)。结论：清热解毒方、软坚散结方均能不同程度地抑制人肺腺癌A549细胞的增殖，其机制可能与下调Bcl-2 mRNA表达有关，从而促进人肺腺癌A549细胞凋亡。</p></sec><sec id="s2"><title>关键词</title><p>清热解毒方，软坚散结方，人肺腺癌A549细胞，Bcl-2</p></sec><sec id="s3"><title>Effects of Qingrejiedu Formula and Ruanjiansanjie Formula on Proliferation and Bcl-2 Expression of A549 Cells<sup> </sup></title><p>Xin Feng<sup>1</sup>, Xiaowei Sun<sup>2</sup>, Lijun Wang<sup>2</sup>, Zhe Gao<sup>2</sup>, Cunzhi Lin<sup>2*</sup></p><p><sup>1</sup>Qingdao University, Qingdao Shandong</p><p><sup>2</sup>The Affiliated Hospital of Qingdao University, Qingdao Shandong</p><p><img src="//html.hanspub.org/file/15-1572020x4_hanspub.png" /></p><p>Received: Feb. 8<sup>th</sup>, 2021; accepted: Feb. 28<sup>th</sup>, 2021; published: Mar. 9<sup>th</sup>, 2021</p><p><img src="//html.hanspub.org/file/15-1572020x6_hanspub.png" /></p></sec><sec id="s4"><title>ABSTRACT</title><p>Objective: To study the effects of Qingrejiedu Formula and Ruanjiansanjie Formula on proliferation and Bcl-2 expression of human lung adenocarcinoma cancer cell A549. Methods: We added different concentrations of Qingrejiedu Formula and Ruanjiansanjie Formula to human lung adenocarcinoma cells A549 and CCK8 method was used to detect cellular proliferation. Flow cytometric was used to detect cell apoptotic. RT-PCR method was used to detect the mRNA expression of Bcl-2. Results: Qingrejiedu Formula and Ruanjiansanjie Formula inhibited the proliferation of A549 cells in a dose-dependent manner (P &lt; 0.05), and down-regulated the expression of Bcl-2 (P &lt; 0.05). Conclusion: Qingrejiedu Formula and Ruanjiansanjie Formula can inhibit the proliferation of A549 cell line in varying degrees, and the mechanism may down-regulate the expression of Bcl-2, so as to induce apoptosis of human lung adenocarcinoma cancer cell A549.</p><p>Keywords:Qingrejiedu Formula, Ruanjiansanjie Formula, Human Lung Adenocarcinoma Cancer Cell A549, B-Cell Lymphoma-2</p><disp-formula id="hanspub.40835-formula11"><graphic xlink:href="//html.hanspub.org/file/15-1572020x7_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2021 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY 4.0).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/15-1572020x8_hanspub.png" /> <img src="//html.hanspub.org/file/15-1572020x9_hanspub.png" /></p></sec><sec id="s5"><title>1. 引言</title><p>肺癌是临床上常见的恶性肿瘤，其发病率和死亡率均居全世界首位。在肺癌的分型中，非小细胞肺癌(NSCLC)约占肺癌总数的80%，其中腺癌是目前最常见的肺癌病理类型 [<xref ref-type="bibr" rid="hanspub.40835-ref1">1</xref>]。肺癌的传统治疗手段是手术、化疗或放疗，但大多数肺癌患者在确诊时已处于晚期，往往对传统治疗手段不能耐受，而中医药在治疗中晚期NSCLC具有稳定病灶、防止肿瘤细胞转移、改善临床症状、提高患者生存质量、延长生存期等显著的优势 [<xref ref-type="bibr" rid="hanspub.40835-ref2">2</xref>]。周仲瑛认为治疗肺癌祛邪重于扶正，治法上以清热解毒、化痰散结、活血化瘀、益气养阴等复法组方为主 [<xref ref-type="bibr" rid="hanspub.40835-ref3">3</xref>]。本研究旨在通过体外实验，检测清热解毒方、软坚散结方对人肺腺癌A549细胞增殖的影响，并初步探讨其作用机制。</p></sec><sec id="s6"><title>2. 材料与方法</title><sec id="s6_1"><title>2.1. 材料</title><sec id="s6_1_1"><title>2.1.1. 细胞株</title><p>人肺腺癌细胞A549，由青岛大学附属医院中心实验室提供。</p></sec><sec id="s6_1_2"><title>2.1.2. 实验药品</title><p>清热解毒方(牡丹皮15 g，栀子10 g，连翘10 g，夏枯草15 g，鱼腥草15 g，金荞麦15 g)，软坚散结方(牡蛎20 g，夏枯草10 g，山慈菇10 g，白花舌蛇草20 g，瓜蒌10 g，半夏10 g)，两组中药方剂配方均由青岛大学附属医院中医科提供，药材均购自青岛大学附属医院中药房。以分析天平精密称取两种按原方比例配伍的各中药免煎颗粒，将其粉碎后置入试管中，分别加入100℃去离子水80 ml振荡溶解，静置放凉，此时所得中药免煎颗粒溶剂浓度相当于原饮片1 g/ml，超净工作台内将药液经0.22 um微孔滤膜除菌，得清热解毒方、软坚散结方原液，4℃冰箱保存备用。根据预实验情况确定两种方剂有效抑制浓度范围，实验时将上述原液用培养液稀释后配置成所需终浓度，分别为2.5、5、10、20、40、80、160 mg/ml后使用。药物均为实验前新鲜配用。</p></sec><sec id="s6_1_3"><title>2.1.3. 实验试剂</title><p>CCK8试剂盒购自大连美仑生物技术有限公司，Annexin V-FITC/PI细胞凋亡检测试剂盒购自上海优宁维生物科技股份有限公司，SYBR&#174; Premix Ex Taq™ II PCR扩增试剂盒购自日本TaKaRa公司，Bcl-2及β-actin (内参)上下游引物均由上海生工生物工程技术服务有限公司合成。</p></sec></sec><sec id="s6_2"><title>2.2. 方法</title><sec id="s6_2_1"><title>2.2.1. 人肺腺癌A549细胞培养及处理</title><p>将A549细胞用DMEM培养基(含10%血清、青霉素100 ug/L，链霉素100 ug/L)于37℃、5% CO<sub>2</sub>饱和湿度培养箱中培养，以0.25%胰蛋白酶消化，选择对数生长期，且生长状态良好的A549细胞随机分为3组：两种不同功效中药方剂组，DMEM培养基阴性对照组。</p></sec><sec id="s6_2_2"><title>2.2.2. CCK8法检测细胞生长抑制率</title><p>选择对数生长期，且生长状态良好的A549细胞，以3 &#215; 10<sup>4</sup>/ml的密度接种到96孔板中，培养过夜。向细胞中添加终浓度分别为2.5、5、10、20、40、80、160 mg/ml的两种不同功效中药方剂，设置添加DMEM培养基的A549细胞为阴性对照组，设置添加DMEM培养基为空白组。每组设3复孔。培养48 h后，常规CCK8显色，用全自动酶标仪在波长450 nm测定各孔吸光度(OD值)。计算细胞生长抑制率，抑制率(%) = [1 − (实验组OD值 − 空白组OD值)/(对照组OD值 − 空白组OD值)] &#215; 100%。应用加权直线回归分析法计算IC50值。以下实验均选用两种中药方剂的IC50值作为实验浓度。每组实验至少重复3次，下同。</p></sec><sec id="s6_2_3"><title>2.2.3. 流式细胞仪检测细胞凋亡率</title><p>选择对数生长期，且生长状态良好的A549细胞，按照1 &#215; 10<sup>5</sup>/ml的密度接种到6孔板中，培养过夜。向细胞中添加两种不同功效的中药方剂，药物浓度为相对应中药方剂的IC50值，设置添加DMEM培养基的A549细胞为阴性对照。培养48 h后，用不含EDTA胰酶消化、离心收集细胞。用预冷的磷酸盐缓冲液(PBS)重悬冲洗、离心收集细胞。用300 ul Binding Buffer (1:10)重悬细胞，加入5 ul Annexin V-FITC，混匀后室温避光孵育15分钟，再加入5 ul溴化丙锭(PI)，混匀后室温避光孵育5分钟，上流式细胞仪检测细胞凋亡率。</p></sec><sec id="s6_2_4"><title>2.2.4. RT-PCR法检测A549细胞Bcl-2 mRNA表达</title><p>选择对数生长期，且生长状态良好的A549细胞，按照1 &#215; 10<sup>5</sup>/ml的密度接种到6孔板中，培养过夜。向细胞中添加两种不同治法的中药方剂，药物浓度为相对应中药方剂的IC50值，设置添加DMEM培养基的A549细胞作为阴性对照。每组设3复孔。培养48 h后，用预冷的磷酸盐缓冲液(PBS)冲洗一次，Trizol裂解细胞，提取RNA并检测RNA浓度和纯度。将RNA反转录为cDNA。RT-PCR检测Bcl-2 mRNA表达。</p></sec><sec id="s6_2_5"><title>2.2.5. 统计学方法</title><p>应用SPSS 22.0软件将实验所得数据进行统计分析，所得数据用平均数 &#177; 标准差( x &#175; &#177; s)表示，两组间比较采用方差分析。*P &lt; 0.05，**P &lt; 0.01，差异有统计学意义。</p></sec></sec></sec><sec id="s7"><title>3. 结果</title><sec id="s7_1"><title>3.1. 不同浓度两组中药方剂对人肺腺癌A549细胞增殖的影响(图1)</title><p>不同浓度两组中药方剂均呈剂量依赖性抑制人肺腺癌A549细胞的增殖。与阴性对照组比较，2.5 mg/ml软坚散结方作用于A549细胞后吸光度下降，差异无统计学意义(P &gt; 0.05)，余不同浓度两组中药方剂作用于A549细胞后吸光度下降，差异均有统计学意义(P &lt; 0.05, P &lt; 0.01)。清热解毒方、软坚散结方的IC50值分别为11.313 mg/ml、23.874 mg/ml。</p><p>图1. 不同浓度两组中药方剂作用于A549细胞后吸光度比较</p></sec><sec id="s7_2"><title>3.2. 细胞凋亡情况(图2)</title><p>细胞经Annexin V-FITC/PI染色后，利用流式细胞仪检测细胞凋亡率，清热解毒方、软坚散结方作用于A549细胞48 h后检测细胞凋亡率(早期凋亡 + 晚期凋亡)分别为8.66%、11.17%，与空白对照组(3.53%)比较，细胞凋亡率增加，差异有统计学意义(P &lt; 0.01)。</p><p>图2. 两组中药方剂作用于A549细胞后凋亡率比较</p></sec><sec id="s7_3"><title>3.3. Bcl-2 mRNA表达(图3)</title><p>与阴性对照组比较，清热解毒方、软坚散结方均能不同程度下调Bcl-2 mRNA表达，差异有统计学意义(P &lt; 0.05，P &lt; 0.01)。</p></sec></sec><sec id="s8"><title>4. 讨论</title><p>中医认为，肿瘤的发生与正气虚损、阴阳失衡、脏腑功能失调、留滞客邪有关，致使气滞血瘀、痰凝毒聚，相互胶结日久形成肿瘤 [<xref ref-type="bibr" rid="hanspub.40835-ref4">4</xref>]，故痰淤热毒、气阴两伤是肺癌的基本病机，而清热解毒、软坚散结即成为治疗肺癌的重要治则 [<xref ref-type="bibr" rid="hanspub.40835-ref3">3</xref>]。</p><p>图3. 两组中药方剂作用于A549细胞后Bcl-2 mRNA相对表达量比较</p><p>研究证实，抑制肿瘤增殖、诱导肿瘤细胞分化和凋亡是中医药抗肿瘤的重要机制 [<xref ref-type="bibr" rid="hanspub.40835-ref2">2</xref>]。细胞凋亡包括外在的死亡受体通路和内在的线粒体信号通路。Bcl-2凋亡信号通路为内源性通路，可分为促凋亡蛋白和抑凋亡蛋白两大类，其中Bax和Bcl-2分别是典型的促凋亡和抑凋亡蛋白。当Bax高表达或者Bcl-2基因低表达所致其比值上升，Bax同源二聚体增多，可引起细胞凋亡增加 [<xref ref-type="bibr" rid="hanspub.40835-ref5">5</xref>]。李小江等观察到具有益气滋阴、活血祛瘀、清热解毒、扶正祛邪功效的消岩汤及其拆方组(清热解毒组、活血化瘀组、益气扶正组)在体外实验中均能抑制人肺腺癌A549细胞的生长 [<xref ref-type="bibr" rid="hanspub.40835-ref6">6</xref>]。研究证实，软坚散结方中多种药物均具有抑制人肺腺癌A549细胞的增殖，诱导人肺腺癌A549细胞凋亡的作用，其中白花蛇草乙醇提取物可呈剂量依赖性抑制人肺腺癌A549细胞的增殖 [<xref ref-type="bibr" rid="hanspub.40835-ref7">7</xref>]。</p><p>本实验采用CCK8法观察不同浓度清热解毒方、软坚散结方对人肺腺癌A549细胞体外增殖作用的影响，结果提示：不同浓度两组中药方剂均呈剂量依赖性抑制A549细胞的增殖，说明清热解毒方、软坚散结方在体外均具有较强的细胞毒性和抑制肿瘤细胞增殖的作用。采用流式细胞仪观察发现，清热解毒方、软坚散结方作用于A549细胞48 h后细胞凋亡率(早期凋亡 + 晚期凋亡)明显增加，提示两组中药方剂均能不同程度诱导A549细胞凋亡。采用PCR法观察发现，清热解毒方、软坚散结方均能不同程度下调Bcl-2表达，提示两组中药方剂诱导A549细胞凋亡的作用机制可能与下调Bcl-2 mRNA表达有关。</p></sec><sec id="s9"><title>5. 结论</title><p>综上所述，清热解毒方、软坚散结方均具有较强的抑制人肺腺癌A549细胞增殖及诱导细胞凋亡的能力，其共同作用机制可能为通过下调Bcl-2 mRNA表达来诱导A549细胞凋亡。因此，清热解毒方、软坚散结方均具有较强的抗肿瘤作用，两种中药方剂不同的作用机制有待进一步阐明。</p></sec><sec id="s10"><title>基金项目</title><p>山东省中医药科技发展计划项目编号：2017-199；青岛市中医课题编号：2020-zyy062。</p></sec><sec id="s11"><title>文章引用</title><p>冯 欣,孙晓伟,王丽君,高 哲,林存智. 清热解毒方与软坚散结方对人肺腺癌A549细胞增殖及Bcl-2表达的影响Effects of Qingrejiedu Formula and Ruanjiansanjie Formula on Proliferation and Bcl-2 Expression of A549 Cells[J]. 临床医学进展, 2021, 11(03): 918-924. https://doi.org/10.12677/ACM.2021.113132</p></sec><sec id="s12"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.40835-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Bray, F., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424.  
&lt;br&gt;https://doi.org/10.3322/caac.21492</mixed-citation></ref><ref id="hanspub.40835-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">成娅婷, 田成旺, 任涛, 张铁军, 冯霞. 中药治疗非小细胞肺癌的临床应用及作用机制研究进展[J]. 药物评价研究, 2016, 39((2): 293-299.</mixed-citation></ref><ref id="hanspub.40835-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">王珊珊. 周仲瑛教授从痰瘀热毒辨治肺癌的临床经验及益肺解毒汤的抗肿瘤实验研究[D]: [博士学位论文]. 南京: 南京中医药大学, 2017.</mixed-citation></ref><ref id="hanspub.40835-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">郑婷婷, 焦丽静, 阙祖俊, 吴静, 许玲. 中药诱导肿瘤凋亡相关机制研究进展[J]. 上海中医药杂志, 2016, 50(10): 103-109.</mixed-citation></ref><ref id="hanspub.40835-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Singh, R., Letai, A. and Sarosiek, K. (2019) Regulation of Apoptosis in Health and Disease: The Balancing Act of BCL-2 Family Proteins. Nature Reviews Molecular Cell Biology, 20, 175-193.  
&lt;br&gt;https://doi.org/10.1038/s41580-018-0089-8</mixed-citation></ref><ref id="hanspub.40835-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">李小江, 贾英杰, 于建春, 张小青, 杜晓玲, 朱津丽, 孟醒. 消岩汤剂拆方配伍对A549肺腺癌细胞体外生长抑制作用研究[J]. 天津中医药, 2015, 32(7): 424-427.</mixed-citation></ref><ref id="hanspub.40835-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Kuo, Y.J., et al. (2015) Ethanol Extract of Hedyotis diffusa Willd Upregulates G0/G1 Phase Arrest and Induces Apoptosis in Human Leukemia Cells by Modulating Caspase Cascade Signaling and Altering Associated Genes Expression Was Assayed by cDNA Microarray. Environmental Toxicology, 30, 1162-1177. &lt;br&gt;https://doi.org/10.1002/tox.21989</mixed-citation></ref></ref-list></back></article>